COMPARATIVE EVALUATION OF THE HTA EVIDENCE REQUIREMENTS AND OUTCOMES FOR DIGITAL HEALTH TECHNOLOGIES IN GERMANY AND UK

被引：0
|
作者：
Gaultney, J. [1 ]
Maier, M. [2 ]
Modesto, C. [3 ]
Lu, M. [4 ]
Eberhardt, A. [5 ]
Chan, E. [6 ]
Barzey, V [6 ]
机构：
[1] IQVIA Ltd, London, England
[2] IQVIA Commercial GmbH & Co OHG, Munich, Germany
[3] IQVIA Solut Portugal Lda, Lisbon, Portugal
[4] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[5] Otsuka Pharma GmbH, Frankfurt, Germany
[6] Otsuka Pharmaceut Europe Ltd, Windsor, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA223
引用
收藏
页码：S362 / S362
页数：1
相关论文
共 50 条
  • [1] CONTRASTING EVIDENCE REQUIREMENTS FOR EARLY ACCESS SCHEMES FOR DIGITAL HEALTH TECHNOLOGIES IN THE UK AND GERMANY: A CHALLENGE FOR MULTI-MARKET EVIDENCE GENERATION PLANNING
    Wieffer, H.
    VALUE IN HEALTH, 2024, 27 (12) : S489 - S489
  • [2] DIGITAL HEALTH APPLICATION (DIGA) VS OTHER DIGITAL HEALTH TECHNOLOGIES (DHT) AS PART OF DISEASE MANAGEMENT PROGRAMS (DMP)ASSESSMENT REQUIREMENTS IN GERMANY DIVERGE BETWEEN HTA AUTHORITIES
    Maier, M.
    Becker, M.
    Boeckmann, D.
    Drews, J.
    Schuller, J. M.
    Bonduelle, D.
    VALUE IN HEALTH, 2023, 26 (12) : S357 - S358
  • [3] ARE DIGITAL HEALTH THERAPEUTICS RESHAPING THE HTA FRAMEWORK FOR HEALTH TECHNOLOGIES?
    Tutulea, E.
    Barchanska, M.
    Perez-Kempner, L.
    VALUE IN HEALTH, 2023, 26 (12) : S326 - S326
  • [4] EMERGENCE OF APPLICATIONS FOR DIGITAL HEALTH TECHNOLOGIES AND DETAILS OF HTA ASSESSMENTS FOR DIGITAL HEALTH IN EUROPE
    Sidhu, C.
    Ohanwusi, E.
    Bending, M. W.
    Sullivan, N.
    VALUE IN HEALTH, 2022, 25 (01) : S193 - S194
  • [5] ADVANCING EVIDENCE TO ACTION: A COMPARISON OF HEALTH TECHNOLOGY ASSESSMENT (HTA) OUTCOMES IN ENGLAND, FRANCE AND GERMANY
    Schaefer, R.
    Hernandez, D.
    Schlander, M.
    VALUE IN HEALTH, 2020, 23 : S70 - S70
  • [6] EXISTING HTA METHODOLOGY FOR DIGITAL HEALTH TECHNOLOGIES (DHTS): A REVIEW OF THE LITERATURE, HTA FRAMEWORKS FOR DHTS AND HTA REPORTS
    Dietz, J.
    Friedrichson, B.
    Jaramillo, C.
    Zacharowski, K.
    Munoz-Lopez, S.
    Fibla-Reixachs, J.
    Ilowiecka, K.
    Segur-Ferrer, J.
    Paone, S.
    Battaglia, L.
    Marchetti, M.
    Prakash, A.
    Kievit, W.
    Oortwijn, W.
    Garrett, Z.
    Dawoud, D.
    VALUE IN HEALTH, 2024, 27 (12)
  • [7] METHODOLOGICAL FRAMEWORKS FOR THE HTA OF DIGITAL HEALTH TECHNOLOGIES: A NATIONAL AND INTERNATIONAL SURVEY
    Segur-Ferrer, J.
    Molto-Puigmarti, C.
    Vivanco-Hidalgo, R.
    VALUE IN HEALTH, 2022, 25 (12) : S296 - S296
  • [8] EVALUATING DIGITAL HEALTH TECHNOLOGIES: A REVIEW OF HTA GUIDANCE AND ASSESSMENTS IN EUROPE
    Mesana, L.
    Farge, G.
    Cheung, L.
    Syed, I. A.
    VALUE IN HEALTH, 2018, 21 : S271 - S271
  • [9] DIFFERENCES AND SIMILARITIES IN THE LEVEL OF EVIDENTIARY REQUIREMENTS REQUIRED FOR ORPHAN DRUGS DURING HTA APPRAISAL IN BULGARIA, FRANCE, GERMANY, SWEDEN, AND THE UK: A COMPARATIVE ANALYSIS
    Djambazov, S.
    Filipov, A.
    Dacheva, A.
    Vutova, Y.
    Vekov, T.
    VALUE IN HEALTH, 2020, 23 : S672 - S672
  • [10] Implementation of a new Digi-HTA process for digital health technologies in Finland
    Haverinen, Jari
    Turpeinen, Miia
    Falkenbach, Petra
    Reponen, Jarmo
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2022, 38 (01)
12345